Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors

Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors

INTRODUCTION. Marburg and Ebola viruses cause severe haemorrhagic fever in humans and primates. Currently, there are no licensed prophylactic vaccines that can simultaneously prevent the spread or reduce the severity of both diseases caused by these filoviruses. The development of effective prophyla...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: T. A. Ozharovskaia, O. V. Zubkova, O. Popova, A. V. Kovyrshina, P. P. Goldovskaya, I. V. Vavilova, I. V. Dolzhikova, E. I. Ermolova, M. S. Kunda, N. N. Ryzhova, O. L. Voronina, D. N. Shcherbinin, D. V. Shcheblyakov, D. Y. Logunov, A. L. Gintsburg
Hōputu: Tuhinga
Reo:Ruhiana
I whakaputaina: Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-10-01
Rangatū:Биопрепараты: Профилактика, диагностика, лечение
Ngā marau:
immunogenicity
glycoprotein gene variants
ebola virus
marburg virus
human adenovirus type 5
recombinant adenoviral vectors
ebola virus disease
marburg virus disease
humoral immune response
Urunga tuihono:https://www.biopreparations.ru/jour/article/view/576
Tags: Tāpirihia he Tūtohu
No Tags, Be the first to tag this record!

Ngā tūemi rite